A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer (vol 350, pg 1081, 2004)

被引：0
作者：
Coombes, RC
机构：
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2004年 / 351卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2461 / 2461
页数：1
相关论文
共 50 条
  • [31] Randomized trial or adjuvant tamoxifen pour years vs two years in node positive breast cancer women.
    Gallén, M
    Alonso, C
    Ojeda, B
    Viladíu, P
    Beltrán, W
    Borrás, J
    Tusquets, I
    Arcusa, A
    Barnadas, A
    Bastús, R
    Balil, A
    Batiste-Alentorn, E
    Guasch, I
    Garau, I
    Boleda, W
    Badia, A
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S56 - S56
  • [32] Switching to exemestane after 2-3 years of adjuvant tamoxifen prolongs disease-free survival, but not overall survival, in postmenopausal women surviving primary breast cancer, compared with continuous tamoxifen
    Davies, C
    CANCER TREATMENT REVIEWS, 2004, 30 (06) : 583 - 588
  • [33] The effect of exemestane on serum lipid profile in postmenopausal women with metastatic breast cancer: a companion study to EORTC Trial 10951, 'Randomized phase II study in first line hormonal treatment for metastatic breast cancer with exemestane or tamoxifen in postmenopausal patients'
    Atalay, G
    Dirix, L
    Biganzoli, L
    Beex, L
    Nooij, M
    Cameron, D
    Lohrisch, C
    Cufer, T
    Lobelle, JP
    Mattiaci, MR
    Piccart, M
    Paridaens, R
    ANNALS OF ONCOLOGY, 2004, 15 (02) : 211 - 217
  • [34] EFFECTS OF TAMOXIFEN ON UTERUS AND OVARIES OF POSTMENOPAUSAL WOMEN IN A RANDOMIZED BREAST-CANCER PREVENTION TRIAL
    KEDAR, RP
    BOURNE, TH
    POWLES, TJ
    COLLINS, WP
    ASHLEY, SE
    COSGROVE, DO
    CAMPBELL, S
    LANCET, 1994, 343 (8909) : 1318 - 1321
  • [35] The effects on lipids of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer
    Gonnelli, S.
    Montagnani, A.
    Cadirni, A.
    Caffarelli, C.
    Montomoli, M.
    Campagna, M. S.
    Petrioli, R.
    Del Santo, K.
    Cuda, C.
    Nuti, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 409 - 409
  • [36] Letrozole reduces spread of early breast cancer after tamoxifen therapy in postmenopausal women
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (09): : 1156 - +
  • [37] Prevalence of osteoporotic fractures in postmenopausal women with breast cancer after tamoxifen therapy.
    Resch, H
    Muschitz, C
    Resch, A
    Wölfl, A
    Biber, E
    Pötter, R
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 : S412 - S412
  • [38] Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
    Nordenskjold, Anna
    Fohlin, Helena
    Rosell, Johan
    Bengtsson, Nils-Olof
    Fornander, Tommy
    Hatschek, Thomas
    Lindman, Henrik
    Malmstrom, Per
    Ryden, Lisa
    Wallgren, Arne
    Stal, Olle
    Nordenskjold, Bo
    BREAST, 2023, 71 : 63 - 68
  • [39] Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
    A Barnadas
    M Gil
    S González
    I Tusquets
    M Muñoz
    A Arcusa
    L Prieto
    M Margelí-Vila
    A Moreno
    British Journal of Cancer, 2009, 100 : 442 - 449
  • [40] Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial
    Barnadas, A.
    Gil, M.
    Gonzalez, S.
    Tusquets, I.
    Munoz, M.
    Arcusa, A.
    Prieto, L.
    Margeli-Vila, M.
    Moreno, A.
    BRITISH JOURNAL OF CANCER, 2009, 100 (03) : 442 - 449
12345